Analyst Whitney Ijem works at CANACCORD and is covering the the Healthcare sector with 37 price targets and ratings documented since 2018 spanning on 13 stocks. Previously, Whitney Ijem worked at GUGGENHEIM.
Whitney Ijem's average stock forecast success ratio is 42.59% with an average time for price targets to be met of 357.22 days.
Most recent stock forecast was given on RYTM, Rhythm Pharmaceuticals, Inc at 02-Mar-2023.
Analyst best performing recommendations are on KRYS (KRYSTAL BIOTECH, INC).
The best stock recommendation documented was for KRYS (KRYSTAL BIOTECH, INC) at 6/21/2019. The price target of $48 was fulfilled within 26 days with a profit of $18.85 (64.67%) receiving and performance score of 24.87.
Average potential price target upside
Currently, out of the existing stock ratings of Whitney Ijem - 1 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
180
$53.18 (41.93%)
150
4 days ago
10/12 (83.33%)
$36.96 (71.21%)
239
Buy
185
$58.18 (45.88%)
185
6 days ago
8/17 (47.06%)
$57.82 (60.99%)
350
Buy
218
$91.18 (71.90%)
200
14 days ago
13/34 (38.24%)
$61.76 (57.40%)
393
Buy
176
$49.18 (38.78%)
160
15 days ago
3/10 (30%)
$42.63 (40.09%)
221
Hold
151
$24.18 (19.07%)
139
15 days ago
22/29 (75.86%)
$19.4 (21.30%)
136
